Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT02063399
Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis
Sponsor: Chinese University of Hong Kong
View on ClinicalTrials.gov
Summary
The purpose of this study is to determine if the screening of nasopharyngeal carcinoma using plasma Epstein-Barr virus DNA analysis would result in the detecting NPC cases at earlier stages and improve survival.
Official title: Prospective 20,000-person Nasopharyngeal Carcinoma (NPC) Screening Programme Using Plasma Epstein-Barr Virus (EBV) DNA Analysis
Key Details
Gender
MALE
Age Range
40 Years - 62 Years
Study Type
OBSERVATIONAL
Enrollment
20302
Start Date
2013-07
Completion Date
2030-06
Last Updated
2026-10-27
Healthy Volunteers
Yes
Conditions
Locations (1)
Chinese University of Hong Kong
Hong Kong, Hong Kong